NeuroOne Medical Technologies Corporation
NMTC
$0.567
-$0.0126-2.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 104.21% | 1.33% | -16.14% | -8.65% | -22.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 104.21% | 1.33% | -16.14% | -8.65% | -22.86% |
| Cost of Revenue | -13.17% | -11.83% | 11.66% | 36.92% | 55.37% |
| Gross Profit | 67.12% | 20.75% | -55.67% | -110.15% | -191.02% |
| SG&A Expenses | 4.51% | 14.08% | 5.53% | 10.34% | 7.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.46% | -0.15% | 8.68% | 23.35% | 29.40% |
| Operating Income | 49.96% | 0.57% | -20.06% | -37.17% | -50.58% |
| Income Before Tax | 46.64% | -3.87% | -19.84% | -36.36% | -50.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 46.64% | -3.87% | -19.84% | -36.36% | -50.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.64% | -3.87% | -19.84% | -36.36% | -50.94% |
| EBIT | 49.96% | 0.57% | -20.06% | -37.17% | -50.58% |
| EBITDA | 51.03% | 0.98% | -19.65% | -36.73% | -50.28% |
| EPS Basic | 61.58% | 29.76% | 18.54% | -1.93% | -25.63% |
| Normalized Basic EPS | 61.44% | 29.48% | 17.29% | -3.45% | -25.12% |
| EPS Diluted | 61.61% | 29.67% | 18.44% | -2.03% | -25.74% |
| Normalized Diluted EPS | 61.42% | 29.48% | 17.29% | -3.45% | -25.12% |
| Average Basic Shares Outstanding | 41.94% | 47.71% | 49.80% | 37.97% | 23.80% |
| Average Diluted Shares Outstanding | 41.99% | 47.71% | 49.80% | 37.97% | 23.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |